Interplay between Copper, Neprilysin, and N-Truncation of β-Amyloid

Inorganic Chemistry
Mariusz MitalSimon C Drew

Abstract

Sporadic Alzheimer's disease (AD) is associated with an inefficient clearance of the β-amyloid (Aβ) peptide from the central nervous system. The protein levels and activity of the Zn2+-dependent endopeptidase neprilysin (NEP) inversely correlate with brain Aβ levels during aging and in AD. The present study considered the ability of Cu2+ ions to inhibit human recombinant NEP and the role for NEP in generating N-truncated Aβ fragments with high-affinity Cu2+ binding motifs that can prevent this inhibition. Divalent copper noncompetitively inhibited NEP ( Ki = 1.0 μM),  while proteolysis of Aβ yielded the soluble, Aβ4-9 fragment that can bind Cu2+ with femtomolar affinity at pH 7.4. This provides Aβ4-9 with the potential to act as a Cu2+ carrier and to mediate its own production by preventing NEP inhibition. Enzyme inhibition at high Zn2+ concentrations ( Ki = 20 μM) further suggests a mechanism for modulating NEP activity, Aβ4-9 production, and Cu2+ homeostasis.

References

Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
Apr 19, 1984·Nature·S Y Assaf, S H Chung
Feb 15, 1993·Archives of Biochemistry and Biophysics·D L MillerK Iqbal
Jul 10, 2002·The Journal of Biological Chemistry·M Hasan MohajeriRoger M Nitsch
Jul 18, 2003·The Journal of Biological Chemistry·Malcolm A LeissringDennis J Selkoe
Jan 30, 2004·Acta Crystallographica. Section D, Biological Crystallography·Christian OefnerGlenn E Dale
Oct 18, 2005·FEBS Letters·Roberta RussoAlessandra Piccini
Dec 1, 2005·Chemical Communications : Chem Comm·Nikhil H Gokhale, J A Cowan
Jun 27, 2007·The American Journal of Pathology·Wesley FarrisDennis J Selkoe
Nov 22, 2007·Biochemical and Biophysical Research Communications·Małgorzata RózgaWojciech Bal
Jan 15, 2009·Journal of Neurochemistry·Peter J CrouchAnthony R White
Jan 12, 2010·Journal of Alzheimer's Disease : JAD·Mi LiDehua Chui
Dec 15, 2010·Science·Kwasi G MawuenyegaRandall J Bateman
Dec 31, 2010·Biophysical Journal·Julijana Milojevic, Giuseppe Melacini
Jun 8, 2012·Cold Spring Harbor Perspectives in Medicine·Colin L Masters, Dennis J Selkoe
Jun 8, 2012·Cold Spring Harbor Perspectives in Medicine·Takaomi Saido, Malcolm A Leissring
Dec 20, 2012·Analytical Chemistry·Bruno AliesChristelle Hureau
Sep 28, 2013·Journal of Alzheimer's Disease : JAD·Julijana MilojevicGiuseppe Melacini
Jun 9, 2014·Neuron·Angela Maria VergnanoPierre Paoletti
May 27, 2016·Science Translational Medicine·Deepak Kumar Vijaya KumarRobert D Moir

❮ Previous
Next ❯

Citations

Jun 25, 2019·Chemical Communications : Chem Comm·Paulina GonzalezPeter Faller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.